Neogen Cash Flow Statement
NEOG / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | -$1.1B | -$9.4M | -$22.9M | $48.3M | $60.9M | $59.5M | $60.2M | $63.1M | $43.8M | $36.6M | $33.5M | $28.2M | $27.2M | $22.5M |
| Depreciation & Amortization | - | $119.5M | $116.7M | $88.4M | $23.7M | $21.0M | $18.4M | $17.6M | $17.1M | $14.7M | $12.2M | $10.6M | $9.2M | $7.4M | $6.2M |
| Operating Cash Flow | - | $58.2M | $35.3M | $41.0M | $68.0M | $81.1M | $85.9M | $63.8M | $69.1M | $60.3M | $35.3M | $43.8M | $21.7M | $26.6M | $22.3M |
| Capital Expenditures | - | $104.6M | $111.4M | $65.8M | $24.4M | $26.7M | $24.1M | $14.7M | $20.9M | $14.6M | $14.2M | $9.6M | $11.5M | $1.5M | $12.4M |
| Free Cash Flow | - | -$46.4M | -$76.2M | -$24.7M | $43.6M | $54.4M | $61.8M | $49.2M | $48.2M | $45.7M | $21.1M | $34.2M | $10.1M | $25.1M | $9.9M |
| Share Buybacks | - | - | - | - | - | - | $3.1M | $3.1M | - | - | - | - | - | - | - |
| FCF Margin | - | -5.2% | -8.2% | -3.0% | 8.3% | 11.6% | 14.8% | 11.9% | 12.1% | 12.8% | 6.6% | 12.1% | 4.1% | 12.1% | 5.4% |